Published in Front Pharmacol on July 02, 2014
A high-content platform to characterise human induced pluripotent stem cell lines. Methods (2015) 0.86
Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture. Biomark Insights (2015) 0.80
Phenotypic Assessment and the Discovery of Topiramate. ACS Med Chem Lett (2016) 0.75
Scaling-Up Techniques for the Nanofabrication of Cell Culture Substrates via Two-Photon Polymerization for Industrial-Scale Expansion of Stem Cells. Materials (Basel) (2017) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell (2004) 16.89
A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol (2007) 13.56
New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature (2007) 13.54
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol (2006) 11.29
Socializing with the neighbors: stem cells and their niche. Cell (2004) 9.40
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol (2003) 8.42
Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41
Naive and primed pluripotent states. Cell Stem Cell (2009) 7.15
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature (2009) 7.04
How were new medicines discovered? Nat Rev Drug Discov (2011) 7.00
The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater (2007) 6.86
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol (2009) 6.76
Derivation of novel human ground state naive pluripotent stem cells. Nature (2013) 5.90
Modelling the long QT syndrome with induced pluripotent stem cells. Nature (2011) 5.68
TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development (2005) 5.66
Exploring and engineering the cell surface interface. Science (2005) 5.54
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92
Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci (2005) 4.86
Designing materials to direct stem-cell fate. Nature (2009) 4.86
Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci U S A (2010) 4.63
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature (2010) 4.38
An extracellular matrix microarray for probing cellular differentiation. Nat Methods (2005) 4.35
Extracellular-matrix tethering regulates stem-cell fate. Nat Mater (2012) 3.94
Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol (2011) 3.87
Epithelial contact guidance on well-defined micro- and nanostructured substrates. J Cell Sci (2003) 3.79
TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol (2008) 3.44
Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells (2008) 3.33
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat Commun (2011) 3.23
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater (2010) 3.11
Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell (2010) 3.05
Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol (2005) 3.03
Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A (2010) 3.01
Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J (2007) 2.91
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain (2008) 2.83
Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell (2010) 2.73
Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons. Science (2013) 2.61
The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet (2006) 2.41
Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell (2013) 2.31
Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet (2011) 2.26
Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil (1993) 2.23
A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods (2010) 2.15
A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell (2013) 2.14
Network formation and degradation behavior of hydrogels formed by Michael-type addition reactions. Biomacromolecules (2005) 2.07
Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation. Physiol Rev (2011) 2.06
Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A (2014) 2.04
Artificial niche microarrays for probing single stem cell fate in high throughput. Nat Methods (2011) 2.03
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell (2013) 2.02
An algorithm-based topographical biomaterials library to instruct cell fate. Proc Natl Acad Sci U S A (2011) 1.99
E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells (2010) 1.97
Patterning network structure to spatially control cellular remodeling and stem cell fate within 3-dimensional hydrogels. Biomaterials (2010) 1.95
Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction (2010) 1.86
High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell (2008) 1.79
Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat Protoc (2012) 1.74
Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression. Nat Biotechnol (2012) 1.74
Cytoskeleton-based forecasting of stem cell lineage fates. Proc Natl Acad Sci U S A (2009) 1.68
Mechanically induced osteogenic differentiation--the role of RhoA, ROCKII and cytoskeletal dynamics. J Cell Sci (2009) 1.66
Activation of ROCK by RhoA is regulated by cell adhesion, shape, and cytoskeletal tension. Exp Cell Res (2007) 1.63
Cancer cell lines for drug discovery and development. Cancer Res (2014) 1.60
Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat Commun (2014) 1.56
Nanotopographical modification: a regulator of cellular function through focal adhesions. Nanomedicine (2010) 1.55
Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment. Annu Rev Biophys (2012) 1.55
Biophysical regulation of epigenetic state and cell reprogramming. Nat Mater (2013) 1.55
Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res (2006) 1.55
Nanotopography influences adhesion, spreading, and self-renewal of human embryonic stem cells. ACS Nano (2012) 1.47
Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc (2011) 1.46
The effect of actin disrupting agents on contact guidance of human embryonic stem cells. Biomaterials (2007) 1.45
Characterization of integrin engagement during defined human embryonic stem cell culture. FASEB J (2009) 1.43
Self-organizing properties of mouse pluripotent cells initiate morphogenesis upon implantation. Cell (2014) 1.38
Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells (2006) 1.38
Increasing the Content of High-Content Screening: An Overview. J Biomol Screen (2014) 1.36
Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells. Stem Cells (2009) 1.36
Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology (2013) 1.34
Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol Bioeng (2009) 1.28
Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells. Cell Adh Migr (2012) 1.27
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci (2013) 1.25
Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proc Natl Acad Sci U S A (2011) 1.25
Mechanics regulates fate decisions of human embryonic stem cells. PLoS One (2012) 1.24
Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol (2012) 1.24
Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PLoS One (2011) 1.23
Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse. Dev Biol (2012) 1.21
Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells. Biophys J (2010) 1.21
Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev (2010) 1.20
Glycosaminoglycan-binding hydrogels enable mechanical control of human pluripotent stem cell self-renewal. ACS Nano (2012) 1.20
Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol (2007) 1.20
Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Rep (2012) 1.16
Integrin-mediated adhesion and stem-cell-niche interactions. Cell Tissue Res (2009) 1.16
Biomaterials: Spotlight on hydrogels. Nat Mater (2009) 1.16
A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation. Nat Commun (2012) 1.14
Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient. Stem Cells (2011) 1.13
The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials (2008) 1.12
Automated maintenance of embryonic stem cell cultures. Biotechnol Bioeng (2007) 1.11
Artificial stem cell niches. Adv Mater (2009) 1.11
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell (2014) 1.10
The impact of manual processing on the expansion and directed differentiation of embryonic stem cells. Biotechnol Bioeng (2008) 1.09
Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation. Stem Cells (2011) 1.08
Directing stem cell fate by controlling the affinity and density of ligand-receptor interactions at the biomaterials interface. Angew Chem Int Ed Engl (2012) 1.05